Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: Radiobiological and dosimetric considerations

被引:60
作者
Guerrero, M
Li, XA
Ma, LJ
Linder, J
Deyoung, C
Erickson, B
机构
[1] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA
[2] Univ Maryland, Dept Radiat Oncol, Baltimore, MD 21201 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 62卷 / 03期
关键词
cervical cancer; IMRT; SIB; radiotherapy;
D O I
10.1016/j.ijrobp.2004.11.040
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Whole-pelvis irradiation (WPI) followed by a boost to the tumor site is the standard of practice for the radiotherapeutic management of locally advanced gynecologic cancers. The boost is frequently administered by use of brachytherapy or, occasionally, external-beam radiotherapy (EBRT) when brachytherapy does not provide sufficient coverage because of the size of the tumor or the geometry of the patient. In this work, we propose using an intensity-modulated radiotherapy (IMRT) simultaneous integrated boost (SIB), which is a single-phase process, to replace the conventional two-phase process involving WPI plus a boost. Radiobiological modeling is used to design appropriate regimens for the IMRT SIB. To demonstrate feasibility, a dosimetric study is carried out on an example patient. Methods and Materials: The standard linear-quadratic (LQ) model is used to calculate the biologically effective dose (BED) and equivalent uniform dose (EUD). A series of regimens that are biologically equivalent to those conventional two-phase treatments is calculated for the proposed SIB. A commercial inverse planning system (Corvus) was used to generate IMRT SIB plans for a sample patient case that used the newly designed fractionations. The dose-volume histogram (DVH) and EUD of both the target and normal structures for conventional treatments and the SIB are compared. A sparing factor was introduced to characterize the sparing of normal structures. Results: Fractionation regimes that are equivalent to the conventional treatments and are suitable for the IMRT SIB are deduced. For example, a SIB plan with 25 X 3.1 Gy (77.5 Gy) to a tumor is equivalent to a conventional treatment of EBRT of 45 Gy to the whole pelvis in 25 fractions plus a high-dose rate (HDR) brachytherapy boost with 30 Gy in 5 fractions. The normal tissue BED is found to be lower for the SIB plan than for the whole-pelvis plus HDR scheme when a sparing factor for the critical structures is considered. This finding suggests that the IMRT SIB has a better therapeutic ratio. Three IMRT SIB plans with 25 X 1.8 Gy to the pelvic nodes and 25 X 2.4 Gy (60 Gy), 25 X 2.8 Gy (70 Gy), and 25 X 3.2 Gy (80 Gy) to the tumor site were generated for the example patient case. The target coverage ranged from 94% to 95.5%. The sparing of bladder and rectum is significantly improved with the 60 to 70 Gy SIB treatments, as compared with the conventional treatments. The proposed SIB treatment can reduce the treatment time to 5 weeks. Conclusions: An IMRT simultaneous integrated boost to replace the conventional two-phase treatments (whole pelvic irradiation followed by brachytherapy or EBRT boost) is radiobiologically and dosimetricaly feasible for locally advanced gynecological cancers that may not be amenable to brachytherapy for anatomic or medical reasons. In addition to its shorter treatment time, the proposed IMRT SIB can provide significant sparing to normal structures, which offers potential for dose escalation. Issues such as organ motion and changing anatomy as tumor responds still must be addressed. (c) 2005 Elsevier Inc.
引用
收藏
页码:933 / 939
页数:7
相关论文
共 23 条
[1]   Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate [J].
Bolger, BS ;
Symonds, RP ;
Stanton, PD ;
Maclean, AB ;
Burnett, R ;
Kelly, P ;
Cooke, TG .
BRITISH JOURNAL OF CANCER, 1996, 74 (08) :1223-1226
[2]   Incorporating biologic measurements (SF2, CFE) into a tumor control probability model increases their prognostic significance:: A study in cervical carcinoma treated with radiation therapy [J].
Buffa, FM ;
Davidson, SE ;
Hunter, RD ;
Nahum, AE ;
West, CML .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (05) :1113-1122
[3]   FITTING OF NORMAL TISSUE TOLERANCE DATA TO AN ANALYTIC-FUNCTION [J].
BURMAN, C ;
KUTCHER, GJ ;
EMAMI, B ;
GOITEIN, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :123-135
[4]   The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy [J].
Chen, SW ;
Liang, JA ;
Yang, SN ;
Ko, HL ;
Lin, FJ .
RADIOTHERAPY AND ONCOLOGY, 2003, 67 (01) :69-76
[5]   Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01 [J].
Eifel, PJ ;
Winter, K ;
Morris, M ;
Levenback, C ;
Grigsby, PW ;
Cooper, J ;
Rotman, M ;
Gershenson, D ;
Mutch, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :872-880
[6]   TOLERANCE OF NORMAL TISSUE TO THERAPEUTIC IRRADIATION [J].
EMAMI, B ;
LYMAN, J ;
BROWN, A ;
COIA, L ;
GOITEIN, M ;
MUNZENRIDER, JE ;
SHANK, B ;
SOLIN, LJ ;
WESSON, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :109-122
[7]   USE OF NORMALIZED TOTAL DOSE TO REPRESENT THE BIOLOGICAL EFFECT OF FRACTIONATED RADIOTHERAPY [J].
FLICKINGER, JC ;
KALEND, A .
RADIOTHERAPY AND ONCOLOGY, 1990, 17 (04) :339-347
[8]   THE LINEAR-QUADRATIC FORMULA AND PROGRESS IN FRACTIONATED RADIOTHERAPY [J].
FOWLER, JF .
BRITISH JOURNAL OF RADIOLOGY, 1989, 62 (740) :679-694
[9]   Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer [J].
Kavanagh, BD ;
Schefter, TE ;
Wu, QW ;
Tong, SD ;
Newman, F ;
Arnfield, M ;
Benedict, SH ;
McCourt, S ;
Mohan, R .
SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (03) :260-271
[10]   CALCULATION OF COMPLICATION PROBABILITY FACTORS FOR NON-UNIFORM NORMAL TISSUE IRRADIATION - THE EFFECTIVE VOLUME METHOD [J].
KUTCHER, GJ ;
BURMAN, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (06) :1623-1630